George V Migausky - Net Worth and Insider Trading

George V Migausky Net Worth

The estimated net worth of George V Migausky is at least $7 Million dollars as of 2024-11-05. George V Migausky is the EVP & CFO of Dyax Corp and owns about 86,350 shares of Dyax Corp (DYAX) stock worth over $3 Million. George V Migausky is also the Director of Immunovant Inc and owns about 109,808 shares of Immunovant Inc (IMVT) stock worth over $3 Million. Details can be seen in George V Migausky's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George V Migausky has not made any transactions after 2023-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of George V Migausky

To

George V Migausky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George V Migausky owns 7 companies in total, including Abeona Therapeutics Inc (ABEO) , Immunovant Inc (IMVTU) , and Dimension Therapeutics Inc (DMTX) among others .

Click here to see the complete history of George V Migausky’s form 4 insider trades.

Insider Ownership Summary of George V Migausky

Ticker Comapny Transaction Date Type of Owner
ABEO Abeona Therapeutics Inc 2020-06-17 director
IMVTU Immunovant Inc 2020-05-15 director
DMTX Dimension Therapeutics Inc 2017-11-07 director
LIMIT LIMIT 2017-04-06 Interim CFO
LIMIT LIMIT 2016-01-22 EVP & Chief Financial Officer
LIMIT LIMIT 2021-09-03 director
LIMIT LIMIT 2023-12-01 director

George V Migausky Latest Holdings Summary

George V Migausky currently owns a total of 2 stocks. Among these stocks, George V Migausky owns 86,350 shares of Dyax Corp (DYAX) as of August 17, 2015, with a value of $3 Million and a weighting of 50.17%. George V Migausky also owns 109,808 shares of Immunovant Inc (IMVT) as of December 1, 2023, with a value of $3 Million and a weighting of 49.83%.

Latest Holdings of George V Migausky

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DYAX Dyax Corp 2015-08-17 86,350 38.41 3,316,704
IMVT Immunovant Inc 2023-12-01 109,808 30.00 3,294,240

Holding Weightings of George V Migausky


George V Migausky Form 4 Trading Tracker

According to the SEC Form 4 filings, George V Migausky has made a total of 0 transactions in Dyax Corp (DYAX) over the past 5 years. The most-recent trade in Dyax Corp is the sale of 125,000 shares on August 17, 2015, which brought George V Migausky around $3 Million.

According to the SEC Form 4 filings, George V Migausky has made a total of 2 transactions in Immunovant Inc (IMVT) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Immunovant Inc is the sale of 12,700 shares on December 1, 2023, which brought George V Migausky around $504,571.

Insider Trading History of George V Migausky

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George V Migausky Trading Performance

GuruFocus tracks the stock performance after each of George V Migausky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George V Migausky is 19.07%. GuruFocus also compares George V Migausky's trading performance to market benchmark return within the same time period. The performance of stocks bought by George V Migausky within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how George V Migausky's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of George V Migausky

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 20.81 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 19.14 LIMIT LIMIT LIMIT LIMIT LIMIT

George V Migausky Ownership Network

Ownership Network List of George V Migausky

No Data

Ownership Network Relation of George V Migausky

Insider Network Chart

George V Migausky Owned Company Details

What does Abeona Therapeutics Inc do?

Who are the key executives at Abeona Therapeutics Inc?

George V Migausky is the director of Abeona Therapeutics Inc. Other key executives at Abeona Therapeutics Inc include Chief Financial Officer Christine Berni Silverstein , SVP & General Counsel Brendan M. O'malley , and director & Chief Executive Officer Vishwas Seshadri .

Abeona Therapeutics Inc (ABEO) Insider Trades Summary

Over the past 18 months, George V Migausky made no insider transaction in Abeona Therapeutics Inc (ABEO). Other recent insider transactions involving Abeona Therapeutics Inc (ABEO) include a net purchase of 50,000 shares made by Vishwas Seshadri , a net sale of 39,290 shares made by Mark Alvino , and a net sale of 6,173 shares made by Michael Amoroso .

In summary, during the past 3 months, insiders sold 0 shares of Abeona Therapeutics Inc (ABEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 93,190 shares of Abeona Therapeutics Inc (ABEO) were sold and 88,758 shares were bought by its insiders, resulting in a net sale of 4,432 shares.

Abeona Therapeutics Inc (ABEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Abeona Therapeutics Inc Insider Transactions

No Available Data

George V Migausky Mailing Address

Above is the net worth, insider trading, and ownership report for George V Migausky. You might contact George V Migausky via mailing address: C/o Dyax Corp., 300 Technology Square, Cambridge Ma 02139.